News
TikTok creators perform 'roles' when sharing their hereditary cancer stories, shaping the health information they share by University of Sheffield edited by Gaby Clark, reviewed by Andrew Zinin ...
Obesity increases the risk of nearly 200 diseases. A new genetic test may be able to predict a young child's risk of obesity in adulthood.
Obesity increases the risk of nearly 200 diseases. A new genetic test may be able to predict a young child's risk of obesity in adulthood.
There is a significant and concerning decline in the genetic diversity of British nightjar populations over the past two centuries, a study from the University of York has found.
Thousands of genetic variants have been identified that increase our risk of obesity, for example, variants that act in the brain and influence our appetite.
For many ant species, caste determines destiny. Queens grow large, sprout wings, and lay eggs; workers stay small, wingless, and industrious. But how these castes develop—and how a young ant's ...
A new genetic analysis using data from over five million people has provided a clearer understanding of the risk of going on to live with obesity.
Researchers at Penn Medicine identified previously undiagnosed genetic conditions in nearly one in four critically ill adults admitted to the ICU. Credit: Abhiram Juvvadi Researchers at the Perelman ...
The FDA has approved garadacimab-gxii for prophylactic use in patients aged 12 years and older with hereditary angioedema, according to a press release from CSL Behring. The approval was based on ...
The FDA has approved a first-of-its-kind treatment for a rare genetic condition that causes frequent, unpredictable, and painful swelling in different parts of the body.
Hereditary leiomyomatosis and renal-cell cancer (HLRCC) is an inherited disorder characterized by germline pathogenic variants in the gene encoding fumarate hydratase and an increased risk of papil ...
Andembry (garadacimab) can help people with hereditary angioedema prevent potentially serious swelling attacks. The FDA has approved Andembry (garadacimab), a once-monthly injection, to prevent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results